697 related articles for article (PubMed ID: 24064285)
1. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
[TBL] [Abstract][Full Text] [Related]
2. Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan.
Hung YP; Tsai PJ; Hung KH; Liu HC; Lee CI; Lin HJ; Wu YH; Wu JJ; Ko WC
PLoS One; 2012; 7(8):e42415. PubMed ID: 22876321
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
4. Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.
Zhang X; Wang X; Yang J; Liu X; Cai L; Zong Z
BMC Infect Dis; 2016 Aug; 16():397. PubMed ID: 27506470
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration.
Hung YP; Lee JC; Tsai BY; Wu JL; Liu HC; Liu HC; Lin HJ; Tsai PJ; Ko WC
J Microbiol Immunol Infect; 2021 Apr; 54(2):276-283. PubMed ID: 31522990
[TBL] [Abstract][Full Text] [Related]
6. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.
Lee YC; Wang JT; Chen AC; Sheng WH; Chang SC; Chen YC
J Microbiol Immunol Infect; 2012 Aug; 45(4):287-95. PubMed ID: 22209696
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of Clostridium difficile colonization.
Hung YP; Lee JC; Lin HJ; Liu HC; Wu YH; Tsai PJ; Ko WC
J Microbiol Immunol Infect; 2015 Jun; 48(3):241-8. PubMed ID: 24890755
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
Kaneria MV; Paul S
J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.
Hung YP; Lin HJ; Tsai BY; Liu HC; Liu HC; Lee JC; Wu YH; Wilcox MH; Fawley WN; Hsueh PR; Tsai PJ; Ko WC
Anaerobe; 2014 Dec; 30():188-92. PubMed ID: 24956433
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors of Clostridium difficile-associated diarrhea in children].
Guo S; Xu XW; Dong F
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1836-40. PubMed ID: 22944235
[TBL] [Abstract][Full Text] [Related]
12. Colonization of Toxigenic
Mi H; Bao R; Xiao Y; Cui Y; Sun W; Shen Y; Shi Q; Chen X; Lin J; Hu B; Gao X
Front Cell Infect Microbiol; 2020; 10():12. PubMed ID: 32083021
[No Abstract] [Full Text] [Related]
13. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
15. Host and pathogen factors for Clostridium difficile infection and colonization.
Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
[TBL] [Abstract][Full Text] [Related]
16. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
17. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.
Shim JK; Johnson S; Samore MH; Bliss DZ; Gerding DN
Lancet; 1998 Feb; 351(9103):633-6. PubMed ID: 9500319
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
19. Do statins protect against the development of Clostridium difficile-associated diarrhoea?
Nseir W; Bishara J; Mograbi J; Mahamid M; Khalaila W; Taha M; Farah R
J Antimicrob Chemother; 2013 Aug; 68(8):1889-93. PubMed ID: 23563740
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-outbreak of Clostridium difficile associated diarrhea (CDAD) in a tertiary-care hospital.
Souza Dias MB; Yamashiro J; Borrasca VL; Stempliuk VA; Araújo MR; Costa SF; Levin AS
Rev Inst Med Trop Sao Paulo; 2010; 52(3):133-7. PubMed ID: 20602022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
